Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism Siglec-9 inhibitors(sialic acid binding Ig like lectin 9 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 28 Apr 2025 | |
COVID-19 | Preclinical | United States | 02 Feb 2023 |